5 курс / Психиатрия и наркология для детей и взрослых (доп.) / Psikhofarmakoterapia_psikhosamoticheskikh
.pdf
АНТИПСИХОТИКИ В ОБЩЕЙ МЕДИЦИНЕ
Критерии метаболического синдрома
Risk factor |
|
NCEP-ATP III |
AHA/NHLB |
|
|
|
|
Abdominal obesity (waist circumference) |
|
|
|
|
|
|
|
Men |
|
> 102 cm |
> 102 cm |
Womer |
|
> 88 cm |
> 88 cm |
Triglycerides |
|
> 150 mg/dL |
> 150 mg/dL or on drug treatment |
|
for elevated triglycerides |
||
|
|
|
|
|
|
|
|
High density lipoprotein (HDL) |
|
|
|
|
|
|
|
Men |
|
< 40 mg/dL |
< 40 mg/dL or on drug treatment |
|
for reduced HDL-cholesterol |
||
|
|
|
|
|
|
|
|
Women |
|
< 50 mg/dL |
< 50 mg/dL or on drug treatment |
|
for reduced HDL-cholesterol |
||
|
|
|
|
Blood pressure |
|
Systolic > 130 |
Systolic > 130 or diastolic > 85 |
|
mmHg or on antihypertensive |
||
|
or diastolic > 85 mmHg |
||
|
|
medication |
|
|
|
|
|
Fasting glucose |
|
> 110 mg/dL |
> 100 mg/dL or on antidiabetic |
|
medication |
||
|
|
|
|
|
|
|
|
AHA/NHLB: American Heart Association/National Heart, Lung and Blood Institute NCEP-ATP III = National Cholesterol Education Program, Adult Treatment Panel, 3rd report